Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01402869 · ClinicalTrials.gov registry record · NA

Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local Anesthetics

A NA study, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
91
Enrollment target

NCT01402869 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 91 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01402869, a NA study, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
91 participants
Enrollment target

Study Summary

To establish and compare maximum methemoglobin blood levels and times to maximum methemoglobin blood levels following the administration of the injectable local anesthetics prilocaine and lidocaine when used for dental treatment in pediatric patients under general anesthesia. Patients will be randomized into three equal study groups. Two of the study groups will receive local anesthetic and the third group will not. Methemoglobin blood levels will be non-invasively monitored and recorded throughout dental treatment for all groups using a Masimo Radical-7 Pulse Co-Oximeter device.

Interventions

  • DRUG 4% prilocaine plain
  • DRUG 2% Lidocaine with 1:100,000 epinephrine

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2011-08
Est. Completion 2012-07
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT01402869

The ClinicalTrials.gov registry entry for NCT01402869 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which 4% prilocaine plain is the first listed.

NCT01402869 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01402869 about?

NCT01402869 is a clinical study titled "Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local Anesthetics". To establish and compare maximum methemoglobin blood levels and times to maximum methemoglobin blood levels following the administration of the injectable local anesthetics prilocaine and lidocaine when used for dental treatment in pediatric patients under general anesthesia. Patients will be random...

What is the current status of trial NCT01402869?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2011-08. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01402869?

The interventions under investigation include: 4% prilocaine plain (DRUG), 2% Lidocaine with 1:100,000 epinephrine (DRUG).

Who is sponsoring clinical trial NCT01402869?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.